Used to treat severely low blood sugar, glucagon can be a lifesaving medication for people with diabetes. Here’s how it works and when and how to use it.

Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.

The US Food and Drug Administration (FDA) has rejected a prefilled syringe version of Regeneron's ophthalmology blockbuster Eylea HD (aflibercept), as manufacturing shortcomings continue to plague the ...

The MarketWatch News Department was not involved in the creation of this content.-- VYVGART(R) SC is first and only neonatal Fc receptor blocker approved to treat CIDP -- Authoriz ...

La Roche Limited (Roche Canada) is pleased to announce today that VABYSMO® (faricimab injection) Pre-Filled Syringe (PFS) is ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has directed Abbott ...

DUBLIN--(BUSINESS WIRE)--"A Practical Overview of Pre-Filled Syringes Training Course (Nov 5th - Nov 6th, 2025)" training has been added to ResearchAndMarkets.com's offering. This course offers a ...

Chase Knickerbocker, Craig-Hallum: Sought clarity on U.S. core adjustments and SCIg market growth. Tharby confirmed "about 14%" U.S. growth and noted SCIg market growth in the "8% to 9% range overall.

Innovations in injectable drug packaging are transforming how medications are delivered, combining safety, convenience, and effectiveness.

Investing.com -- Formycon has launched FYB201/Ranivisio as the first ranibizumab biosimilar available in a pre-filled syringe format in Europe, starting in France in October 2025. The company plans to ...

Polpharma Biologics today announced Ranivisio® PFS (ranibizumab biosimilar pre-filled syringe), is now commercially available in France. Ranivisio® is the first Lucentis® biosimilar which is offered ...

Here are three important regulatory changes affecting parenteral packaging that pharmaceutical companies need to be aware of ...